Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This term is **non-specific**: it denotes an alternative choice between **ropivacaine** and **levobupivacaine**, two distinct long-acting amino-amide local anesthetic drugs, rather than a single molecular entity or a co-formulated combination. Both reversibly inhibit voltage-gated sodium channels in peripheral nerves, preventing action-potential initiation and propagation to produce regional anesthesia and analgesia. In the provided rotator-cuff-repair study, either agent may be used for loco-regional anesthesia. Ropivacaine injection is indicated for local or regional anesthesia and acute pain management. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da1ce22b-6a8e-40a2-afbb-011fa3ed3a8b))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ropivacaine or levobupivacaine.